- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -
IRIDEX Granted Patent for MicroPulse™ Technology for Dose Control of Laser Energy During Eye Surgery
Posted By Dr. Ari Weitzner On August 21, 2010 @ 11:57 pm In Glaucoma,New Technologies,Retina | Comments Disabled
On Thursday, IRIDEX announced the issuance of a patent covering its MicroPulse™ technology providing ophthalmologists with fine dose control of laser energy during eye surgery on patients suffering from diabetic retinopathy and other sight-threatening retinal and glaucoma disorders. According to the company, treatments using MicroPulse technology demonstrate favorable outcomes and significantly less damage to healthy retinal structures compared to traditional continuous wave laser treatment.
Laser products such as IRIDEXs’s IQ 577 that incorporate the MicroPulse control technology covered by the recent patent have recently been introduced to the market.
Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com
URL to article: http://eyedocnews.com/003355-iridex-granted-patent-for-micropulse%e2%84%a2-technology-for-dose-control-of-laser-energy-during-eye-surgery/
URLs in this post:
[1] Read the full release: http://www.prnewswire.com/news-releases/iridex-granted-us-patent-for-micropulse-technology---a-fine-dose-control-technology-enabling-tissue-sparing-eye-surgeries-with-visible-lasers-100967664.html
Click here to print.
Copyright © 2008 Eye Doc Talk. All rights reserved.